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NMRProton-translocating transhydrogenase is found in the inner membranes of animal mitochondria, and in the
cytoplasmic membranes of many bacteria. It catalyses hydride transfer from NADH to NADP+ coupled to in-
ward proton translocation. Evidence is reviewed suggesting the enzyme operates by a “binding-change”
mechanism. Experiments with Escherichia coli transhydrogenase indicate the enzyme is driven between
“open” and “occluded” states by protonation and deprotonation reactions associated with proton transloca-
tion. In the open states NADP+/NADPH can rapidly associate with, or dissociate from, the enzyme, and hy-
dride transfer is prevented. In the occluded states bound NADP+/NADPH cannot dissociate, and hydride
transfer is allowed. Crystal structures of a complex of the nucleotide-binding components of Rhodospirillum
rubrum transhydrogenase show how hydride transfer is enabled and disabled at appropriate steps in cataly-
sis, and how release of NADP+/NADPH is restricted in the occluded state. Thermodynamic and kinetic studies
indicate that the equilibrium constant for hydride transfer on the enzyme is elevated as a consequence of the
tight binding of NADPH relative to NADP+. The protonation site in the translocation pathway must face the
outside if NADP+ is bound, the inside if NADPH is bound. Chemical shift changes detected by NMR may
show where alterations in protein conformation resulting from NADP+ reduction are initiated. This article
is part of a Special Issue entitled: 17th European Bioenergetics Conference (EBEC 2012).
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Since its discovery in the 1960s proton-translocating (formerly
“energy-linked”) transhydrogenase has presented an interesting sub-
ject for bioenergetics research. In the “forward” physiological reaction
the enzyme couples the reduction of NADP+ by NADH, a hydride-
transfer reaction, to the inward translocation of protons across the
inner membrane of mitochondria and the cytoplasmic membrane of
some bacteria (Fig. 1). One H+ is translocated across the membrane
per hydride transferred between nucleotides [1]. Thus, the mass ac-
tion ratio of transhydrogenase ([NADPH][NAD+] / [NADP+][NADH])
can be driven to values of approx 500 by the proton electrochemical
gradient (Δp) generated by the respiratory chain [2].
Transhydrogenase in bacteria provides NADPH for amino acid
synthesis [3,4], and for glutathione reduction, required to minimise
oxidative damage in the cell [5]. In animal mitochondria a role in glu-
tathione reduction has also received strong support [6], although theenine dinucleotide; AcPdAD+,
dADH, acetyl pyridine adenine
opean Bioenergetics Conference
rights reserved.question remains as to why transhydrogenase operates alongside
other active generators of NADPH that are not coupled to the con-
sumption of Δp [7]. Studies on the enzyme have taken on renewed
signiﬁcance with recent ﬁndings that (i) over-expression of the en-
zyme in bacteria can lead to increased amounts of commercially valu-
able products [8], and (ii) a strain of mice with a deletion in the gene
coding for transhydrogenase has a form of glucose intolerance resem-
bling human Type II diabetes [9,10].
The availability of genome sequences now provides information on
the remarkable distribution of transhydrogenase amongst species. The
enzyme is very rare in the Archaea, and in some groups of Bacteria,
such as the Firmicutes (which include Gram-positive species). In some
other bacterial taxa the enzyme is common but the distribution is
often patchy even amongst related groups. Species of bacteriawithmul-
tiple copies of the transhydrogenase genes are not uncommon. In the
protists, fungi and invertebrates the distribution is also highly irregular.
For example, the transhydrogenase gene is present inNeurospora crassa,
and absent in Saccharomyces cerevisiae; present in Anopheles gambiae,
and absent in Drosphila melanogaster. The enzyme may be present in
all vertebrates but is absent from the few higher plants whose genomes
have been sequenced. The factors responsible for the irregular distribu-
tion amongst species are not yet evident. A soluble, non-energy linked
transhydrogenase, a ﬂavoprotein having sequence similarity with glu-
tathione reductase, is also found in some bacteria [11] (though rarely,
if at all, in eukaryotes). Its distribution amongst bacterial species
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Fig. 1. The reaction catalysed by proton-translocating transhydrogenase.
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proton-translocating transhydrogenase, and the functional relationship
between the two enzymes (if any) remains to be established.
The purpose of this article is to review and sharpen the “binding-
change” model for the coupling of proton-translocating transhydro-
genase to Δp. The model will be outlined, the evidence for it brieﬂy
reviewed, and some details discussed. The nature of the hydride-
transfer step, and the nucleotide-afﬁnity changes during turnover of
the enzyme, provide the focus.
2. The structure of proton-translocating transhydrogenase
Due to different gene fusions during evolution, the polypeptide
composition of transhydrogenase varies amongst species (there
are four commonly found arrangements) but this probably has little
effect on either the organisation of enzyme components or the en-
zyme mechanism. Thus, transhydrogenase has three components
(Fig. 2): dI, which binds NAD+ and NADH, and dIII, which bindsA B
C
dIII dIII
dIII
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Fig. 2. The structure of the dI2dIII1 complex from R.rubrum transhydrogenase.
PDB ID: 2OO5 (2.6 Å resolution) [23]; dI(A) and dI(B) are the two dI polypeptides in
the complex. Panel A, surface representation; panel B, showing positions of the
bound nucleotides, and the probable positions of the second dIII component, and the
two dII components in the membrane; panel C, detail of the nicotinamide (and ribose)
rings at the hydride-transfer site. The * (in panels A and B) marks the position of helix
D/loop D.NADP+ and NADPH, protrude from the membrane; dII with its
proton-conducting channel spans the membrane (12–14 predicted
transmembrane helices depending on species). The three-dimensional
structure of the complete transhydrogenase has not yet been elucidated
but several high-resolution structures of the parts of the enzyme that
protrude from the membrane are available. Thus, there are X-ray struc-
tures of different nucleotide-bound forms of dI from Rhodospirillum
rubrum [12,13] and Escherichia coli transhydrogenases [14], and of dIII
from the bovine [15], human [16] and R. rubrum [17] enzymes. There
is also a solution (NMR) structure of R. rubrum dIII with bound
NADP+ [18]. Despite suggestions to the contrary [19], the latter is an in-
dependent structure, and all measured NOE distances ﬁt the model
well. Unfortunately, the solution structure of E. coli dIII was not com-
pleted, although the NMR data provided some valuable information
[19].
The most useful X-ray structure for understanding features of the
mechanism of action of transhydrogenase is that of the dI2dIII1 com-
plex from R. rubrum, which is shown in Fig. 2 (see refs [20–24]).
The complex has two dI components and one dIII. The probable asso-
ciation of the dI2dIII1 complex with the two membrane-spanning dII
components, and with the second, “missing” dIII (see [20]), is also
shown diagramatically in Fig. 2. Thus, the intact enzyme is a
“dimer” of two dI–dII–dIII “monomers”. The structure in Fig. 2 has
tetrahydro-NAD (designated H2NADH), a high redox potential ana-
logue of NADH, in dI, and NADP+ in dIII. This mimicks the transition
state for hydride transfer but does not allow the reaction to proceed
[23].
According to Fig. 2 the nicotinamide rings of the bound nucleo-
tides lie some considerable distance (perhaps ~30 Å) from the proba-
ble transmembrane proton-translocation pathway through dII. This
supports earlier suspicions [25] that the coupling between proton
translocation and hydride transfer is mediated by conformational
changes.
3. The binding-change mechanism for proton-translocating
transhydrogenase
In principle, any step on the reaction path could be coupled to pro-
ton translocation, and lead to thermodynamic equilibrium between
transhydrogenation and Δp. However, this would not necessarily be
kinetically efﬁcient. Transhydrogenase in the cell usually operates
under conditions where it consumes the energy of Δp to bind NADH
and NADP+ from a solution (the bacterial cytoplasm or the mitochon-
drial matrix), where their concentrations are relatively low, and then
release NAD+ and NADPH into the same solution, where their con-
centrations are relatively high. To ensure reaction intermediates are
well-populated (to give rapid turnover) this requires that the Kd
values for NADH and NADP+ should be relatively low during sub-
strate binding, and that those for NAD+ and NADPH should be rela-
tively high during product release. However, this creates a problem
for the enzyme. If the substrate nucleotides were bound tightly rela-
tive to the product nucleotides during hydride transfer, the redox
potential difference driving the step would be unfavourable, and the
subsequent reaction intermediate would be under-populated. To cir-
cumvent this problem we proposed a “binding-change” mechanism,
in which the relative binding afﬁnities, speciﬁcally for NADP+ and
NADPH, change during catalysis [26–29].
The essence of the binding-change mechanism is that transhydro-
genase is driven between an “open state” and an “occluded state” by
the protonation and deprotonation reactions associated with proton
translocation (Fig. 3). The relative binding afﬁnities of NADP+ and
NADPH are changed in the occluded state relative to those in the
open state to favour forward hydride transfer.
There has been a notable convergence of the views of the Göte-
borg transhydrogenase group towards this binding-change model.
Thus, in contrast to their earlier proposals [30,31], the mechanism
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Fig. 3. The binding-change mechanism of proton-translocating transhydrogenase. The
pairs of thick horizontal lines represent the bacterial or mitochondrial membrane.
The thick vertical lines represent transhydrogenase in different intermediate confor-
mations, α, β, γ and δ. Binding sites for nucleotides are located in the peripheral com-
ponents of the protein facing the inside aqueous phase. Binding sites for protons (X)
are located within the membrane with an aspect towards either the outside (α and
β) or the inside (γ and δ) aqueous phases. The black shells indicate that bound nucle-
otides or bound protons cannot dissociate from their sites in that particular conforma-
tion. Conformational changes are indicated by **. The arrows indicate the forward
reaction of transhydrogenase. For simplicity, NADH is depicted as binding to α, and
NAD+ as dissociating prior to the formation of δ. In fact NADH and NAD+ can probably
reach rapid equilibrium binding with all four intermediates on the reaction path.
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the interconversion of open/occluded states, with the hydride-transfer
step conﬁned to the occluded state containing tightly-bound
NADP(H). This is essentially the binding-change mechanism described
[26–29]. It is appropriate now therefore to consider the details and con-
straints of the mechanism in a little more detail.
4. Key steps in the binding-change mechanism
The following model coherently explains the coupling between
nucleotide chemistry and proton translocation, and is supported by ex-
perimental data described in subsequent paragraphs. The description
should also raise issues for consideration when the high-resolution
structure of the intact enzyme is eventually solved.
Four key intermediates are predicted in a minimal mechanism
(Fig. 3). In the absence of nucleotides transhydrogenase can adopt
either the α or the δ conformation. Both are in an open state. α
binds NADP+ favourably relative to NADPH, and can bind a proton
from the outside aqueous phase. δ binds NADPH favourably relative
to NADP+, and can bind a proton from the inside aqueous phase.
Without bound nucleotides and protons the α and δ conformations
can interconvert. In Fig. 3 NADH and NADP+ are shown binding to
the α intermediate at the start of the forward reaction. Hydride trans-
fer between these bound nucleotides is prevented in the open states
because the dihydronicotinamide ring of the NADH and the nicotin-
amide ring of the NADP+ are too far apart. The binding of H+ from
the outside then produces a conformational change to intermediate
β, an occluded state of the enzyme. In this conformation, (i) both
the bound NADP+ and the bound H+ are prevented from dissociating
from their sites—they are occluded from the solvent, (ii) the binding
of NADPH becomes favoured relative to NADP+, increasing theequilibrium constant of the hydride-transfer reaction, and (iii) hydride
transfer between nucleotides is kinetically enabled by the movement
of the dihydronicotinamide ring of the NADH towards the nicotinamide
ring of the NADP+. Hydride transfer ensues. The production of bound
NADPH now leads to a conformational change to intermediate γ in
which the position (or aspect) of the protonation site is switched
towards the inside of the membrane. In γ the NADPH and the proton
are still unable to dissociate. The γ intermediate undergoes a ﬁnal con-
formational change to an open form which can release its proton,
NADPH and NAD+ to the inside aqueous phase, and thus revert to inter-
mediate δ.
5. General comments on the binding change mechanism
The essential feature of this mechanism is the interconversion of
the open and occluded states. It permits changes in the relative afﬁn-
ities of NADP+ and NADPH while they remain bound to the enzyme;
it permits the operation of a gating mechanism to ensure that hydride
transfer proceeds only when the redox potentials of the nucleotides
are appropriately poised by their relative binding afﬁnities; and it
permits changes in the location of the proton-binding sites towards
either the inside or outside of the membrane to enable coupling
with Δp. The pathway of intermediates is strictly determined by “se-
lectivity rules” [33] to prevent unwanted slip (hydride transfer with-
out proton translocation and vice versa). In Fig. 3 NADH is shown
binding to the α intermediate, and NAD+ is shown dissociating
from the open form preceding intermediate δ. In fact, bound NAD+
and NADH can probably exchange with solvent NAD+ and NADH in
all the intermediates shown in the ﬁgure, and with unchanging Kd
values—this does not lead to any slip in the mechanism.
The increase in the afﬁnity for NADPH relative to NADP+ during
the conversion of the α to the β intermediate to favour forward hy-
dride transfer is, of course, a “thermodynamic effect”, and we can ex-
pect the Kd of NADPH to decrease relative to that of NADP+ by a factor
of perhaps 103 (Section 6.2). Furthermore, to prevent the enzyme
from slipping it is essential to avoid dissociation of NADP+, NADPH
and of protons from their sites in intermediates β and γ on the time
scale of coupled turnover (~20 s−1). Thus, the pathways for dissocia-
tion of these species must be restricted during the conformational
changes responsible for the formation of the occluded state (effective
koff values decrease). The pathways for association would also be-
come restricted but this would not affect productive turnover since
the NADP+, NADPH and H+ bind in the open state. A purely thermo-
dynamic device for minimising the rate of NADP+, NADPH and H+
dissociation from the occluded states (by greatly lowering the respec-
tive Kd values leading to very “tight binding”) is conceivable but less
likely because it would demand a large free energy change to remove,
for example, very tightly-bound NADPH in the conversion of γ to δ
during forward transhydrogenation. The favoured “kinetic restric-
tion” on the release of these species allows a more moderate distribu-
tion of equilibrium constants, and therefore an equalised population
of the four intermediates, to support good rates of reaction. It
smooths out the ΔG proﬁle and avoids thermodynamic “pits” [34].
All of the steps linking intermediates α, β, γ and δ in Fig. 3 are asso-
ciated with protein conformational changes (labelled **) that require
participation of events in both the nucleotide-binding sites and the
proton-translocation machinery (motor). Thus, each of these four con-
formational changes can take place (i.e., the respective selectivity rule
is satisﬁed) only if both the nucleotide-binding sites and the proton-
motor site—both “ends” of the coupling conformational change—are ap-
propriately conﬁgured. From Fig. 3, these conformational changes must
therefore all take place across a substantial region of the transhydrogen-
asemolecule, and involve both the dII and dIII components. Those in the
conversion of α→β and γ→δmust also involve dI.
The depths (and local dielectic constants) of the proton input and
output channels, to and from, X in Fig. 3 determine the fraction of Δp
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(α→β) and the deprotonation step (γ→δ), respectively; this follows
from the well-known description of the chemiosmotic “proton well”
[35]. If the channels are not deep, then the movement of X during
the conformational changes associated with β→γ and δ→α would
necessarily have a component perpendicular to the plane of the
membrane (see Fig. 3). Depending on the nature of X (e.g. whether
His or Asp/Glu—see Section 6.6) this movement would involve elec-
trophoretic charge displacement, either inward (if imidazol+, during
β→γ) or outward (if COO−, during δ→α) down the fraction of the
electric potential gradient, Δψ, “unused” in the proton channels.
Thus, some of the energy of Δp may be used to drive one or other of
these two conformational changes. For example, if the equilibrium
constant for δ→α is increased by Δp, then more of the enzyme
form favouring NADP+ binding relative to NADPH binding would
accelerate forward transhydrogenation.
6. Evidence for the binding-change mechanism
6.1. The cyclic reaction in intact transhydrogenase—evidence for the
occluded state
The “cyclic reaction” (though not originally described as such)
was ﬁrst demonstrated in reconstituted bovine transhydrogenase by
Fisher's group [36,37], and then Rydstrom's group [38], but its signif-
icance was not explained. An investigation of the cyclic reaction in
puriﬁed, detergent-dispersed transhydrogenase from E. coli led to
greater clarity [39]. The cyclic reaction is the reduction of AcPdAD+
(an NAD+ analogue) by NADH in the presence of either NADP+ or
NADPH. Detailed studies on the stereochemistry and steady-state
kinetics of the reaction [39–41] established that the cyclic pathway
is related to forward and reverse transhydrogenation, as shown dia-
grammatically in Fig. 4. A crucial ﬁnding was that, at low pH (b 6.5
in the E. coli enzyme), the forward and reverse reactions are blocked
but the rates of both types of cyclic reaction (the NADP+-dependent,
and the NADPH-dependent) are greatly elevated [39]. Thus, under
these conditions the cyclic reaction takes place within an enzyme
state (E' in Fig. 4) from which NADP+ and NADPH do not signiﬁcantly
dissociate but in which hydride-transfer between bound nucleotidesE
E'.NADP+
E'.NADPH
E.NADPH
NADH
NAD+ DAdPcA +
AcPdADH
NADP+
H+in
forward cyclic “reverse”
E.NADP+
H+out
E
NADPH
Fig. 4. The cyclic transhydrogenation reaction. E represents conformations of the en-
zyme in which bound NADP+/NADPH can rapidly exchange with free NADP+/NADPH
in the solvent. E′ represents conformations in which bound NADP+/NADPH cannot
rapidly exchange with free NADP+/NADPH in the solvent. In all conformations
bound NAD+/NADH/AcPdAD+/AcPdADH can rapidly exchange with free NAD+/
NADH/AcPdAD+/AcPdADH in the solvent but only some association/dissociation reac-
tions of these nucleotides are shown. Hydride transfer can take place only in E′.(and the binding of NADH and release of NAD+) operate at a rapid
rate. These are the deﬁning properties of the occluded state as illus-
trated in Fig. 3. To explain the pH dependences of the reactions, con-
version of the occluded state to the open state (to allow dissociation
of either NADPH in forward transhydrogenation or NADP+ in re-
verse) is accompanied by the release of a proton. In Fig. 3 H+ release
to the inside accompanies dissociation of NADPH during γ→δ and, in
the reverse reaction, H+ release to the outside accompanies dissocia-
tion of NADP+ during β→α. Consistent with this picture, the cyclic
reaction catalysed by bacterial transhydrogenase in membrane vesi-
cles does not catalyse proton translocation [26,30].
Low concentrations of Zn2+ have the same effect on the intact
E. coli enzyme as decreasing pH, blocking forward and reverse trans-
hydrogenation but increasing the rate of the cyclic reaction [42–44].
The effect is not additive with that due to low pH, and thus probably
has a similar origin. Evidently, the Zn2+ binds to a site in the proton
transfer pathway, and blocks conversion of the occluded to the open
state, recalling inhibition by these ions of proton transfer pathways
in other proteins (see [44]).
A number of mutants of intact E. coli transhydrogenase are more
inhibited in reverse transhydrogenation than in the cyclic reaction.
These include mutants in the α subunit of the enzyme (at αHis450
[45]), and the “αQRML-deletion” mutant [46]), and in the membrane-
spanning part of the β subunit (at βHis91 [46–48], βAsn222 [48],
βGly252 [49]). There are notably several such mutants in helix 14 [50],
and in the so-called "hinge region" [51], as well as in the membrane-
peripheral dIII at βGlu361 [52], β392 [52]). A consideration of Figs. 3
and 4 indicates that the common behaviour of these mutants can be
explained if they disrupt the conformational changes responsible for in-
terconversion of the open and occluded states (during steps α→β and
γ→δ). That the mutations are located in different parts of the transhy-
drogenase protein (speciﬁcally in both dII and dIII), would thus support
the view that these conformational changes extend across themolecule.
The location of themutation sites in a high-resolution structure of trans-
hydrogenase, and a systematic analysis of their pH and nucleotide con-
centration dependences would be revealing.
6.2. The cyclic reaction and hydride transfer in dI2dIII1 complexes
Separately expressed dI and dIII proteins from R. rubrum transhy-
drogenase readily form dI2dIII1 complexes on mixing [53]. Similarly,
E. coli dI and dIII proteins form a (somewhat weaker) complex (of,
as yet, undetermined stoichiometry) [54], and several hybrid com-
plexes involving proteins from different species have also been de-
scribed [55–58]. Across a wide range of pH all these complexes
catalyse only very low rates of steady-state forward and reverse trans-
hydrogenation but rapid rates of the cyclic reaction. The dIII compo-
nents in the complexes are probably all associated with tightly-bound
NADP+ and NADPH, whose dissociation is extremely slow. From
Fig. 4 these properties suggest that dI2dIII1 complexes are locked into
a conformation which resembles the occluded state of the intact
enzyme [20,26–28,53] (and see [59,60] for a sophistication of these
arguments). We suggested that the locking phenomenon arises be-
cause the membrane-spanning dII is absent from the complexes, thus
preventing the conformational changes between the nucleotide-
binding sites and the proton-motor site that take place in the intact en-
zyme during turnover (see Fig. 3): the membrane-peripheral dI2dIII1
complex defaults into an occluded-state-like conformation.
The rapid rate of the cyclic reaction in dI2dIII1 complexes indicates
that the hydride transfer steps must be “fast”. The ease of handling of
the protein, its stability and solubility, permitted a kinetic analysis of
the R. rubrum complex that reveals characteristics of hydride-transfer
hitherto unavailable from experiments with intact enzymes. Upon
mixing AcPdAD+ and dI2dIII1 complexes loaded with NADPH in
the stopped-ﬂow spectrophotometer, a rapid, single turnover burst
of hydride transfer (k≈600 s−1) occurs before the reaction subsides
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release of the product NADP+ (k≈0.03 s−1) [61]. This provides valu-
able corroboration of the scheme in Fig. 4. Similarly, in complementa-
ry experiments, a rapid single-turnover burst of NADP+ reduction by
AcPdADH (k≈100 s−1) precedes the very slow, steady-state (for-
ward) reaction limited by NADPH release (k≈0.0006 s−1) [28]. In
both types of experiment it was shown (at appropriate measuring
wavelengths) that the oxidation rate of the hydride-donor nucleotide
precisely matches the reduction rate of the acceptor nucleotide dur-
ing the burst, thus illustrating direct transfer of H- [28,62].
The measurement of rates of hydride transfer between the physi-
ological nucleotides was made possible by engineering a unique Trp
into the dIII component of R. rubrum dI2dIII1 complexes; the ﬂuores-
cence of this Trp is lower when NADPH is bound to the protein than
when NADP+ is bound [29] (and see [54]). Hydride transfer from
NADH→NADP+ was too fast to measure by stopped-ﬂow [63] but a
continuous-ﬂow device showed that the rate constant approaches
~21000 s−1, which incidentally is much larger than rate constants
determined for oxidation/reduction of nicotinamide nucleotides in
the soluble dehydrogenases [64].
NAD+ and NADH rapidly associate with, and dissociate from,
R. rubrum dI2dIII1 complexes, and the ratios of associative and dissocia-
tive rate constants [63] correspond to Kd values determined in equilib-
rium experiments (~3×10−4 M and ~2×10−5 M, respectively,
[65–67]). Ratios of the forward and reverse rate constants for hydride
transfer during the burst (see above) show that the equilibrium con-
stant for the NADH→NADP+ reaction is elevated by >36 fold relative
to that in free solution [64], and for the AcPdADH→NADP+ reaction,
by 6–16 fold [28]. To achieve this elevation the binding of NADPH at
the hydride-transfer step must be much tighter than the binding of
NADP+. In titration experiments it was independently shown that the
Kd for NADPH was ~270-fold lower than that for NADP+ [29]. These
data are consistent with the idea (Fig. 3) that tight NADPH relative to
NADP+ binding in the occluded state drives the hydride-transfer step
forward, even allowing for the unfavourable, (somewhat) tight binding
of NADH relative to NAD+.
If the afﬁnity for NADPHwere relatively high also at the point dur-
ing forward enzyme turnover where NADP+ needs to bind from the
solvent (i.e., in the open state), then the efﬁciency of the enzyme
would be lowered. Apparent Kd values for the binding of NADP+
(1.6×10−5 M) and NADPH (8.7×10−7 M) to puriﬁed, intact,
detergent-dispersed E. coli transhydrogenase were determined by
isothermal titration calorimetry [68] and ATR-FTIR [69]. However, in
the terms of Fig. 3 these values are compounded from several equilib-
ria associated with the open forms of the enzyme, and cannot pres-
ently be resolved into their separate components. For α→β to be
kinetically competent, the α intermediate must bind NADP+ perhaps
5–10 times more tightly than NADPH, and the ratio of Kd(NADPH) to
Kd(NADP+) would thus increase by a factor of ~103 during the con-
version of the open to the occluded state.
6.3. The structure of the hydride-transfer site in dI2dIII1 complexes
Crystal structures of dI2dIII1 complexes show how hydride transfer
between nucleotides is effected in the occluded state. At the dI–dIII in-
terface the nicotinamide ring of the NADP+ and the tetrahydronicoti-
namide ring of the H2NADH analogue lie adjacent to, but slightly
offset from one another, in approximately parallel planes, and with
their C4N atoms about 3.4 Å apart (Fig. 2B and C). With physiological
nucleotides similarly located in this “proximal” organization, only
small positional ﬂuctuations would be required to permit transfer of
the C4 pro-R hydrogen of NADH to C4N on the si face of NADP+, and
give the “A–B” reaction stereochemistry long since established [70].
The arrangement of the rings determined in this crystal structure
resembles a low-energy transition state for hydride transfer deter-
mined in ab initio quantum mechanical calculations using 1-methylanalogues of nicotinamide and dihydronicotinamide [23]. It is likely
that this proximal nucleotide organisation corresponds to “enabled”
hydride transfer in the occluded state (see Fig. 3).
6.4. Conformational changes in the gating of hydride transfer
NADH (and analogues) in the dI subunit which is not associated
with dIII adopts a different conformation to that described above
[20,22,23]. When superimposed over the proximal arrangement, the
adenosine moiety is relatively unchanged in its protein binding pocket
but the dihydronicotinamide ring (or its tetra-analogue) is displaced
by cumulative rotations, particularly in the pyrophosphate and ribose
phosphate bonds, giving a “distal” organisation. The rotation of the
dihydronicotinamide ring, and the increase in the (modelled) C4N to
C4N distance to >5 Å, is expected to prevent hydride transfer between
the nucleotides. Displacement of the NADH dihydronicotinamide from
proximal to distal therefore provides an explanation for the disabling
of hydride transfer in the transition from the occluded to the open states
of the intact transhydrogenase during catalysis. The shift between
the proximal and distal NADH is accompanied (in several X-ray
structures [12,13,20,22–24]) by a small relative rotation of the two do-
mains which comprise dI. This domain rotation may be linked to the
conformational changes accompanying the α→β and γ→δ transitions
in Fig. 3, and thus be responsible for the proximal–distal (on/off) switch
for hydride transfer. The dihydronicotinamide ring of NADH is held by
the “RQD loop” of dI. Substitution of the highly-conserved Arg127,
Gln132, Asp135 and Ser138 in this loop by site-directed mutagenesis
leads to extremely large decreases in the rate constant for hydride
transfer in dI2dIII1 complexes [71,72]. Crystal structures of the mutant
complexes suggest these residues are involved in the correct proximal
positioning of the dihydronicotinamide ring for hydride transfer to
NADP+.
NMR studies show that a loop in the isolated dI of R. rubrum trans-
hydrogenase (the “mobile loop”) closes down over NADH (and
NAD+) during nucleotide binding [67]. This might exclude water
from the hydride-transfer site [67], or perhaps have a role in the prox-
imal–distal switch of the (dihydro)nicotinamide ring.
6.5. Other conformational changes which may relate to the
binding-change mechanism
Crystal structures of dI2dIII1 complexes (and of isolated dIII) sug-
gest why dissociation of bound NADP+ and NADPH from the occlud-
ed state of the intact enzyme might be heavily restricted. In these
structures, which behave as though they are locked in the occluded
state (see Section 6.2), loop E in dIII, with a conserved Gly–Tyr–Ala
sequence at its apex, arches over the bound nucleotide, making con-
tact with the pyrophosphate and ribose moieties, at least partly
explaining the restricted NADP+ and NADPH release [20,22–24].
This suggestion is consistent with the ﬁnding that mutation of either
the apex Gly or Tyr residues to Cys in E. coli dIII results in a signiﬁcant
increase in the rate of NADPH dissociation from the protein [73,74].
Evidently, the mutation loosens the loop, and enhances nucleotide re-
lease. In the intact wild-type enzyme conversion of the occluded to
the open state during catalysis (at either γ→δ or β→α in Fig. 3,
depending on the direction of reaction) will involve a controlled loos-
ening/retraction of loop E prior to NADP+ or NADPH release.
X-ray crystallography of isolated dIII [17,22] and of dI2dIII1 com-
plexes [20,22,23] has not revealed any structural differences between
the NADP+- and NADPH-bound proteins. Factors responsible for the
relatively tight-binding of NADPH manifestly do not arise from large
structural rearrangements. The highly-conserved Arg90 (R. rubrum
dIII numbering) is located close to the bound nucleotide (~4.5 Å
from Nε to N1N), and may have a role in favouring NADPH binding
over NADP+. Mutation of the equivalent residue in intact E. coli trans-
hydrogenase leads to a drastic loss of enzyme activity [75].
1844 J.B. Jackson / Biochimica et Biophysica Acta 1817 (2012) 1839–1846According to Fig. 3 the reduction of NADP+ in the β→γ step is
thought to trigger a conformational change in dII which results in the
(occluded) proton-binding site in the translocation pathway switching
its aspect towards the inside aqueous phase. Obviously, this conforma-
tional change cannot take place in either isolated dIII or in dI2dIII1 com-
plexes because dII is absent. However, 2DNMR experiments on isolated
dIII from both R. rubrum [76] and E. coli [73,77] reveal a set of chemical-
shift changes in the amide NH groups when bound NADP+ is replaced
with NADPH. These magnetic changes might reﬂect initial events in
the predicted conformational change. Thus, mapping the chemical-
shift changes onto X-ray structures of dIII [16] shows that they occur,
not only in the binding pocket of the nicotinamide ring of the bound
NADP+/NADPH, but also extend some distance into loop E (see
above), and into helix D/loop D, a striking feature that protrudes from
the protein surface (see Fig. 2). It was proposed that, in the intact trans-
hydrogenase, helix D/loop D interacts with structural elements project-
ing from the surface of the membrane-spanning dII and the path of the
requisite conformational change (from NADP+/NADPH to helix D/loop
D to dII and the proton-translocation pathway) can thus be envisaged. A
buried, highly-conserved Asp in helix D (Asp132 in R. rubrum) may
have an important role in conformational interactions in this region of
the protein [15,16,52,78].
Crystallization of R. rubrum dIII at low pH in the presence of deu-
terium oxide leads to a structure in which helix D/loop D is “closed”
against the bound nucleotide [17]. A similar, modiﬁed crystal struc-
ture was observed in both NADP+ and NADPH-bound forms of the
protein suggesting perhaps that, if they represent real events during
enzyme turnover, these changes in helix D/loop Dmight partly reﬂect
conformational alterations between the open and occluded states
(the α→β and γ→δ transitions), and see [79]. The NMR data for R.
rubrum [18] and E. coli dIII [78] do not reveal equivalent conforma-
tions in solution structures.
6.6. The proton motor of transhydrogenase
Because of the subunit composition of transhydrogenase, it seems
unlikely that a rotary catalytic mechanism of the type found in ATP
synthase can operate. A reciprocatingmechanism is much more likely.
Fig. 3 shows such a device in only the barest outline but we previously
suggested a model to illustrate how elements in the proton motor
might diffuse during operation [79]. Since conformational changes
in the transhydrogenase mechanism must occur across a substantial
part of the protein, we suggested that the relative motions of trans-
membrane helices in dII (“motor” and “stator” helices), and rigid ele-
ments in dIII and dI, might play a role in transmission. The so-called
hinge region might also be important in this context [51]. Incidental-
ly, the diagrammatic character of our model (Fig. 6 in ref [79]) should
not be underappreciated, and the cartoon was not intended to pro-
vide a basis for distance determinations (compare [19]).
The question as to which amino-acid sidechains might be involved
in the transhydrogenase proton motor has been addressed by exam-
ining sequences in different species, and by site-directed mutagenesis
of charged residues in the dII component of the E. coli enzyme
[45,47,48,50,51,80–84]. However, experimental analysis is not yet
discriminating enough to determine the role of mutated residues.
Thus, the identity of “X” in Fig. 3 is not known. His91 in Helix 9 of
E. coli transhydrogenase was suggested to be involved in the trans-
membrane proton pathway [45–48,81,83,84], and is therefore a can-
didate. However, in transhydrogenases from many bacterial species
the His is replaced by Asn, and this detracts from the concept. Another
candidate is the highly conserved Asp213 (E. coli numbering) which
is almost invariant. Although hydropathy algorithms place Asp213
in a cytoplasmic loop between transmembrane helices, that analysis
is not strong enough to rule out the possibility that this residue re-
sides more deeply in the membrane. Mutagenesis of this residue in
E. coli strongly inhibits transhydrogenase activity [47].6.7. Asymmetry in the transhydrogenase dimer
From the gene organisation, and from studies on puriﬁed
detergent-dispersed transhydrogenase [85,86], the intact enzyme is
a “dimer” of two dI–dII–dII “monomers”. However, both solution ex-
periments [66] and crystal structures [20] show that only one dIII
polypeptide is stably bound to the dI dimer in the R. rubrum dI2dIII1
complex. There is an indication from solution NMR experiments
that a second dIII can bind to the complex but only with very low af-
ﬁnity [76]. Unfortunately, there is currently no information on the
polypeptide organisation of dIdIII complexes from other species.
The two dI polypeptides in crystal structures of the R. rubrum dI2dIII1
complex [20,22–24] (and also those of the isolated dI dimer [12]) adopt
slightly different conformations. For example, there are differences in
the relative rotation of the two domains of each dI polypeptide, in the
structures of the bound nucleotide (see Section 6.4), and in the “β-hair-
pin” [23]. A second dIII will not model into the structure of the dI2dIII1
complex in a complementary position to the ﬁrst without sidechain
clashing. Thus, there is an intrinsic asymmetry in the complex [20]. On
the basis that this reﬂects an asymmetry in the intact enzyme, it was
suggested that the conformations of the two dI–dII–dIII monomers of
transhydrogenase alternate during turnover—they operate 180° out of
phase [87]. In terms of the binding-change mechanism (Fig. 3) this
would mean that α→β→γ→δ→α in one dI–dII–dIII monomer
would run concurrently with γ→δ→α→β→γ in the other. Thus, in
Fig. 2B the dI(B) polypeptide and its associated dIII and dII are in the β
intermediate, whereas dI(A), and its associated dIII and dII are in the δ
intermediate. This alternation of sites would require tight conforma-
tional coupling between the two monomers but could help smooth
out the ΔG proﬁle of the steps, for example, if a step with an unfavour-
able ΔG in one monomer were linked to a step with a favourable ΔG in
the other. There is some biochemical evidence [88,89] supporting such
an alternating-site mechanism for transhydrogenase.
7. Future directions
Solving the high resolution structure of the intact enzyme is clear-
ly the most important target for future research on transhydrogenase.
In our hands the protein from E. coli is a better candidate for crystal-
lization studies than that from R. rubrum. It is active and soluble at
fairly high concentrations (>10 mg ml−1) in a number of detergents
but, to date, has failed to give good crystals (NPJ Cotton, SAWhite and
JB Jackson, unpublished). Perhaps more effort needs to be focussed on
restricting the conformational mobility of the protein.
The binding-change mechanism and its daughter, the alternating-
sites mechanism, make speciﬁc, testable predictions about the nature
of nucleotide binding to transhydrogenase. There have been exten-
sive studies on the nucleotide-binding properties of isolated dI and
dIII, and dI2dIII1 complexes but little work on the intact enzyme.
The large amounts of intact enzyme required for binding studies can
now be routinely prepared, and mutants which appear to be defective
in transitions between the open and occluded states are available.
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